Lipoprotein apheresis for the treatment of elevated circulating levels of lipoprotein(a): a critical literature review

被引：18
作者：
Franchini, Massimo [1 ]
Capuzzo, Enrico [1 ]
Liumbruno, Giancarlo M. [2 ]
机构：
[1] Carlo Poma Hosp, Dept Haematol & Transfus Med, Mantua, Italy
[2] Italian Natl Blood Ctr, Natl Inst Hlth, Rome, Italy
来源：
BLOOD TRANSFUSION | 2016年 / 14卷 / 05期
关键词：
lipoprotein apheresis; lipoprotein(a); thrombosis; TRANSFER PROTEIN INHIBITOR; CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; FAMILIAL HYPERCHOLESTEROLEMIA; LIPID APHERESIS; DOUBLE-BLIND; RISK-FACTOR; LDL-C; SAFETY; EFFICACY;
D O I：
10.2450/2015.0163-15
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Lipoprotein(a), which consists of a low-density lipoprotein (LDL) particle linked to an apolipoprotein(a) moiety, is currently considered an independent risk factor for cardiovascular disease due to its atherogenic (LDL-like) and prothrombotic (plasminogen-like) properties. The aim of this review is to provide an overview of the current and newer therapies for lowering increased lipoprotein(a) levels, focusing on lipoprotein apheresis. After a systematic literature search, we identified ten studies which, overall, documented that lipoprotein apheresis is effective in reducing increased lipoprotein(a) levels and cardiovascular events.
引用
收藏
页码：413 / 418
页数：6
相关论文
共 60 条
[1]  
Akaike M, 2002, CLIN CHEM, V48, P1454
[2]   Relationship of Apolipoproteins A-1 and B, and Lipoprotein(a) to Cardiovascular Outcomes The AIM-HIGH Trial (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglyceride and Impact on Global Health Outcomes) [J].
Albers, John J. ;
Slee, April ;
O'Brien, Kevin D. ;
Robinson, Jennifer G. ;
Kashyap, Moti L. ;
Kwiterovich, Peter O., Jr. ;
Xu, Ping ;
Marcovina, Santica M. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (17) :1575-1579
[3]   Lipoprotein(a) levels and risk of future coronary heart disease [J].
Bennet, Anna ;
Di Angelantonio, Ernanuele ;
Erqou, Sebhat ;
Eiriksdottir, Gudny ;
Sigurdsson, Gunnar ;
Woodward, Mark ;
Rumley, Ann ;
Lowe, Gordon D. O. ;
Danesh, John ;
Gudnason, Vilmundur .
ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (06) :598-608
[4]   Hyperlipoproteinemia(a): Clinical significance and treatment options [J].
Berthold, Heiner K. ;
Gouni-Berthold, Ioanna .
ATHEROSCLEROSIS SUPPLEMENTS, 2013, 14 (01) :1-5
[5]   A 52-Week Placebo-Controlled Trial of Evolocumab in Hyperlipidemia [J].
Blom, Dirk J. ;
Hala, Tomas ;
Bolognese, Michael ;
Lillestol, Michael J. ;
Toth, Phillip D. ;
Burgess, Lesley ;
Ceska, Richard ;
Roth, Eli ;
Koren, Michael J. ;
Ballantyne, Christie M. ;
Monsalvo, Maria Laura ;
Tsirtsonis, Kate ;
Kim, Jae B. ;
Scott, Rob ;
Wasserman, Scott M. ;
Stein, Evan A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (19) :1809-1819
[6]   Latest developments in the treatment of lipoprotein (a) [J].
Bos, Sven ;
Yayha, Reyhana ;
van Lennep, Jeanine E. Roeters .
CURRENT OPINION IN LIPIDOLOGY, 2014, 25 (06) :452-460
[7]   Meta-analysis of the effect of nicotinic acid alone or in combination on cardiovascular events and atherosclerosis [J].
Bruckert, Eric ;
Labreuche, Julien ;
Amarenco, Pierre .
ATHEROSCLEROSIS, 2010, 210 (02) :353-361
[8]   Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease. [J].
Cannon, Christopher P. ;
Shah, Sukrut ;
Dansky, Hayes M. ;
Davidson, Michael ;
Brinton, Eliot A. ;
Gotto, Antonio M., Jr. ;
Stepanavage, Michael ;
Liu, Sherry Xueyu ;
Gibbons, Patrice ;
Ashraf, Tanya B. ;
Zafarino, Jennifer ;
Mitchel, Yale ;
Barter, Philip .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (25) :2406-2415
[9]   Niacin and fibrates in atherogenic dyslipidemia: Pharmacotherapy to reduce cardiovascular risk [J].
Chapman, M. John ;
Redfern, Jan S. ;
McGovern, Mark E. ;
Giral, Philippe .
PHARMACOLOGY & THERAPEUTICS, 2010, 126 (03) :314-345
[10]   Polymorphism in the apolipoprotein(a) gene, plasma lipoprotein(a), cardiovascular disease, and low-dose aspirin therapy [J].
Chasman, Daniel I. ;
Shiffman, Dov ;
Zee, Robert Y. L. ;
Louie, Judy Z. ;
Luke, May M. ;
Rowland, Charles M. ;
Catanese, Joseph J. ;
Buring, Julie E. ;
Devlin, James J. ;
Ridker, Paul M. .
ATHEROSCLEROSIS, 2009, 203 (02) :371-376
123456